Teva Investigational Site 14833 — Norristown, Pennsylvania

Teva Investigational Site 14833 is a clinical research site located in Norristown, Pennsylvania, United States 19403.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 14833 has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Norristown

Browse all research sites in Pennsylvania · View every site in Norristown

• Mercy Suburban Hospital and Cancer Center
• Suburban Community Hospital and Cancer Center
• Keystone Clinical Studies
• Luitpold Pharmaceuticals
• Novo Nordisk Investigational Site
• Research Site
• Pearl Clinical Research
• Pfizer Investigational Site
• Local Institution
• GSK Investigational Site
• US1124
• Dr. Cherian Verghese

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 14833?

Teva Investigational Site 14833 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 14833 conducted?

Teva Investigational Site 14833 has 1 clinical trials on record. Their work covers Schizophrenia.

Is Teva Investigational Site 14833 accredited by Crixeo Clinical Trials?

Teva Investigational Site 14833 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 14833?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.